Advertisement
BRKR vs TMO
Which Stock Would AI Choose? Bruker (BRKR) vs. Thermo Fisher Scientific (TMO) Stock Comparison
Key Takeaways
- Bruker (BRKR) is a smaller player focused on high-performance scientific instruments, while Thermo Fisher Scientific (TMO) operates as a diversified leader in life sciences tools, diagnostics, and services with significantly larger scale.
- In recent weeks, BRKR shares have shown higher volatility and notable analyst-driven upside, including multiple price target increases, contrasting with TMO’s more stable trading range ahead of its Q2 2026 earnings release.
- BRKR reported Q1 2026 revenue of $823.4 million with modest reported growth but organic contraction, while TMO posted stronger Q1 revenue expansion of 6% to $11.01 billion alongside EPS beats.
- Market positioning favors TMO for broad sector exposure and capital deployment flexibility, whereas BRKR offers targeted exposure to research instrumentation with potentially higher percentage price swings.
- Relative performance in the recent period highlights BRKR’s outperformance in certain momentum metrics compared with TMO’s emphasis on consistent execution and upcoming catalysts.
- Sector sentiment remains constructive for both within life sciences, though BRKR’s smaller market capitalization introduces greater sensitivity to individual product launches and analyst revisions.
Introduction
Bruker Corporation (BRKR) and Thermo Fisher Scientific Inc. (TMO) represent two distinct segments within the life sciences and analytical instrumentation space. This comparison examines their business models, recent market activity, and relative positioning to assist traders and investors evaluating exposure to scientific tools and diagnostics. Portfolio managers, sector specialists, and active traders monitoring healthcare and research spending trends may find the analysis relevant when assessing diversification, growth profiles, and risk-adjusted opportunities in the current environment.
BRKR Overview and Recent Performance
Bruker Corporation develops and supplies high-performance scientific instruments and analytical solutions used in life science research, materials analysis, and diagnostics. The company’s offerings span magnetic resonance, mass spectrometry, and related technologies that support molecular and cellular exploration. In recent market activity, BRKR shares have experienced volatility amid mixed Q1 2026 results, with reported revenue of $823.4 million reflecting 2.7% year-over-year growth offset by organic decline. Guidance for full-year 2026 remains unchanged. Analyst commentary has turned supportive in recent weeks, with several firms raising price targets, contributing to sentiment shifts. Broader timeframe references show the stock trading within a wide 52-week range and displaying sensitivity to product launches and research funding trends.
TMO Overview and Recent Performance
Thermo Fisher Scientific Inc. serves as a comprehensive provider of life science solutions, including analytical instruments, laboratory consumables, diagnostics, and pharmaceutical services. Its scale enables participation across research, clinical, and biopharma end markets. Recent performance reflects steady execution following a solid Q1 2026 report that showed 6% revenue growth to $11.01 billion and adjusted EPS expansion. The company is scheduled to report Q2 results later in July, maintaining focus on operational efficiency and capital allocation. In recent weeks, TMO shares have traded within a relatively contained range, supported by the firm’s diversified revenue base and ongoing acquisition integration. Broader market references indicate resilience tied to sustained demand for scientific infrastructure.
Trending AI Robots
Tickeron maintains a curated selection of AI-powered trading bots through its Trending AI Robots section. The platform offers hundreds of AI Trading Bots that trade thousands of different tickers, yet only those demonstrating the strongest alignment with prevailing market conditions receive placement in the trending roster. Available bots exhibit wide variation in trading styles, strategies, timeframes, performance statistics, and ticker coverage, allowing users to explore options suited to distinct risk tolerances and objectives. Performance metrics across the selection typically span a range of win rates, drawdown profiles, and return expectations depending on the specific bot configuration. For additional details on current trending options, visit the Trending AI Robots page.
Head-to-Head Comparison
Bruker (BRKR) operates with a narrower focus on specialized instrumentation, creating higher exposure to research and development spending cycles, while Thermo Fisher Scientific (TMO) delivers diversified revenue across instruments, consumables, and services, supporting greater stability. Recent momentum has favored BRKR on analyst revisions and percentage price moves, whereas TMO has emphasized consistent quarterly delivery and larger-scale acquisitions. Risk factors differ materially: BRKR’s smaller market capitalization amplifies sensitivity to individual catalysts, while TMO contends with integration complexity and broader macroeconomic influences on lab spending. Sector exposure overlaps in life sciences yet diverges in emphasis, with BRKR leaning toward pure research tools and TMO encompassing diagnostics and pharma services. Market sentiment in recent weeks reflects constructive views on both, tempered by BRKR’s higher volatility versus TMO’s defensive characteristics.
Tickeron AI Verdict
Based on observable factors including trend consistency, earnings stability, and relative positioning, Tickeron’s AI models currently assign a modestly higher probabilistic preference to Thermo Fisher Scientific (TMO). The larger company’s diversified revenue streams and upcoming earnings visibility provide a more stable profile compared with Bruker (BRKR)’s narrower focus and recent organic pressures, though both remain subject to sector-specific dynamics.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKR is a Hold and TMO is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BRKR’s FA Score shows that 1 FA rating(s) are green whileTMO’s FA Score has 2 green FA rating(s).
- BRKR’s FA Score: 1 green, 4 red.
- TMO’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BRKR’s TA Score shows that 3 TA indicator(s) are bullish while TMO’s TA Score has 6 bullish TA indicator(s).
- BRKR’s TA Score: 3 bullish, 5 bearish.
- TMO’s TA Score: 6 bullish, 4 bearish.
Price Growth
BRKR (@Medical/Nursing Services) experienced а +2.71% price change this week, while TMO (@Medical Specialties) price change was +3.38% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.32%. For the same industry, the average monthly price growth was -0.68%, and the average quarterly price growth was -16.83%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.81%. For the same industry, the average monthly price growth was +8.40%, and the average quarterly price growth was +4.35%.
Reported Earning Dates
BRKR is expected to report earnings on Aug 05, 2026.
TMO is expected to report earnings on Jul 23, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.32% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (+0.81% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| BRKR | TMO | BRKR / TMO | |
| Capitalization | 9.11B | 198B | 5% |
| EBITDA | 306M | 11.7B | 3% |
| Gain YTD | 27.303 | -7.648 | -357% |
| P/E Ratio | 74.88 | 29.36 | 255% |
| Revenue | 3.46B | 45.2B | 8% |
| Total Cash | N/A | 1.12B | - |
| Total Debt | 1.67B | 43.2B | 4% |
BRKR | TMO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 28 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 13 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 82 | |
SMR RATING 1..100 | 92 | 62 | |
PRICE GROWTH RATING 1..100 | 39 | 48 | |
P/E GROWTH RATING 1..100 | 4 | 33 | |
SEASONALITY SCORE 1..100 | 85 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TMO's Valuation (13) in the Medical Specialties industry is somewhat better than the same rating for BRKR (50). This means that TMO’s stock grew somewhat faster than BRKR’s over the last 12 months.
TMO's Profit vs Risk Rating (82) in the Medical Specialties industry is in the same range as BRKR (100). This means that TMO’s stock grew similarly to BRKR’s over the last 12 months.
TMO's SMR Rating (62) in the Medical Specialties industry is in the same range as BRKR (92). This means that TMO’s stock grew similarly to BRKR’s over the last 12 months.
BRKR's Price Growth Rating (39) in the Medical Specialties industry is in the same range as TMO (48). This means that BRKR’s stock grew similarly to TMO’s over the last 12 months.
BRKR's P/E Growth Rating (4) in the Medical Specialties industry is in the same range as TMO (33). This means that BRKR’s stock grew similarly to TMO’s over the last 12 months.
| BRKR | TMO | |
|---|---|---|
| RSI ODDS (%) | 7 days ago 74% | 1 day ago 58% |
| Stochastic ODDS (%) | 1 day ago 65% | 1 day ago 56% |
| Momentum ODDS (%) | 1 day ago 68% | 1 day ago 67% |
| MACD ODDS (%) | 1 day ago 71% | 1 day ago 59% |
| TrendWeek ODDS (%) | 1 day ago 71% | 1 day ago 61% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 61% |
| Advances ODDS (%) | 14 days ago 69% | 1 day ago 61% |
| Declines ODDS (%) | 3 days ago 73% | 8 days ago 63% |
| BollingerBands ODDS (%) | 1 day ago 69% | 1 day ago 49% |
| Aroon ODDS (%) | 1 day ago 71% | 1 day ago 55% |
Advertisement